QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (39) Citing Articles via Google Scholar Google Scholar Articles by Kantor, L. Articles by Gnegy, M. E. Search for Related Content PubMed PubMed Citation Articles by Kantor, L. Articles by Gnegy, M. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMPHETAMINE DOPAMINE POTASSIUM RESERPINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 1999, 19(10):3801-3808

Enhanced Amphetamine- and K⁺-Mediated Dopamine Release in Rat Striatum after Repeated Amphetamine: Differential Requirements for Ca²⁺- and Calmodulin-Dependent Phosphorylation and Synaptic Vesicles

Lana Kantor, G. H. Keikilani Hewlett, and Margaret E. Gnegy

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0634

After cessation of repeated, intermittent amphetamine, we detected an emergent Ca²⁺-dependent component of amphetamine-induced dopamine release and an increase in calmodulin and Ca²⁺- and calmodulin-dependent protein kinase activity in rat striatum. This study examined the involvement of calmodulin-dependent protein kinase II (CaM kinase II) and synaptic vesicles in the enhanced Ca²⁺-dependent dopamine release in response to amphetamine or K⁺ in rat striatum. Rats were pretreated for 5 d with 2.5 mg/kg amphetamine or saline and withdrawn from drug for 10 d. The selective CaM kinase II inhibitor KN-93 (1 µM), but not the inactive analog KN-92, attenuated the Ca²⁺-dependent amphetamine-mediated dopamine release from amphetamine-pretreated rats but had no effect in saline-pretreated controls. [³H]Dopamine uptake was unaltered by repeated amphetamine or KN-93 and was Ca²⁺ independent. Striatal dopamine release stimulated by 50 mM KCl was enhanced twofold after repeated amphetamine compared with that in saline controls but was unaffected by KN-93. To examine the requirement for dopaminergic vesicles in the Ca²⁺-dependent dopamine release, we administered reserpine to saline- and amphetamine-pretreated rats 1 d before killing. Reserpine pretreatment did not affect amphetamine-mediated dopamine release from either pretreatment group but completely ablated K⁺-mediated dopamine release. Reserpine did not disrupt the ability of 1 µM KN-93 to block the Ca²⁺-dependent amphetamine-mediated dopamine release from amphetamine-pretreated rats. The results indicate that the enhanced dopamine release elicited by amphetamine from chronically treated rats is dependent on Ca²⁺- and calmodulin-dependent phosphorylation and is independent of vesicular dopamine storage. On the contrary, the enhanced depolarization-mediated vesicular dopamine release is independent of Ca²⁺- and calmodulin-dependent phosphorylation.

Key words: repeated amphetamine; dopamine transport; reserpine; CaM kinase II; depolarization; phosphorylation

---

Copyright © 1999 Society for Neuroscience  0270-6474/99/19103801-08$05.00/0

This article has been cited by other articles:

				Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842. [Abstract] [Full Text] [PDF]

				R. D. Blakely, L. J. DeFelice, and A. Galli Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them Physiology, August 1, 2005; 20(4): 225 - 231. [Abstract] [Full Text] [PDF]

				L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051. [Abstract] [Full Text] [PDF]

				D. L. Roman, S. N. Saldana, D. E. Nichols, F. I. Carroll, and E. L. Barker Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 679 - 687. [Abstract] [Full Text] [PDF]

				P. Vezina, D. S. Lorrain, G. M. Arnold, J. D. Austin, and N. Suto Sensitization of Midbrain Dopamine Neuron Reactivity Promotes the Pursuit of Amphetamine J. Neurosci., June 1, 2002; 22(11): 4654 - 4662. [Abstract] [Full Text] [PDF]

				J. M. Canals, N. Checa, S. Marco, P. Akerud, A. Michels, E. Perez-Navarro, E. Tolosa, E. Arenas, and J. Alberch Expression of Brain-Derived Neurotrophic Factor in Cortical Neurons Is Regulated by Striatal Target Area J. Neurosci., January 1, 2001; 21(1): 117 - 124. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help